Shareholder Update 23 May 2016 Dear Shareholder, Phylogica Limited (ASX: PYC) is transitioning from a drug discovery platform company to a company with drug development capability. As part of this transition, the company

First Page		Document Content
Date: 2016-05-23 20:32:37		Shareholder Update 23 May 2016 Dear Shareholder, Phylogica Limited (ASX: PYC) is transitioning from a drug discovery platform company to a company with drug development capability. As part of this transition, the company Add to Reading List Source URL: phylogica.com Download Document from Source Website File Size: 204,74 KB Share Document on Facebook